Your browser doesn't support javascript.
loading
Patient's perception: shorter and more severe prodromal phase in GBA-associated PD.
Zimmermann, M; Gaenslen, A; Prahl, K; Srulijes, K; Hauser, A-K; Schulte, C; Csoti, I; Berg, D; Brockmann, K.
Afiliação
  • Zimmermann M; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Gaenslen A; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Prahl K; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Srulijes K; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Hauser AK; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Schulte C; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Csoti I; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
  • Berg D; Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
  • Brockmann K; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Eur J Neurol ; 26(4): 694-698, 2019 04.
Article em En | MEDLINE | ID: mdl-30107068
ABSTRACT

BACKGROUND:

Prevalence and time of occurrence of prodromal symptoms of Parkinson's disease (PD) in relation to the onset of classical motor manifestation varies between patients. Possible modifying factors might be different genetic architectures predisposing to varying burden of manifestations.

OBJECTIVES:

To characterize the prodromal phase in PD patients with heterozygous mutations in the GBA gene compared to PD patients without GBA mutation.

METHODS:

In a retrospective design, 151 participants [47 PD patients carrying a GBA mutation (PDGBA ), 52 idiopathic PD patients (PDidiopathic ), 52 healthy elderly (CON)] underwent a validated structured interview designed to assess prevalence and time of occurrence of prodromal symptoms.

RESULTS:

PDGBA showed a higher prevalence of prodromal symptoms and almost simultaneous occurrence of non-motor and early motor symptoms shortly before PD diagnosis whereas PDidiopathic reported a longer prodromal phase starting with non-motor symptoms.

CONCLUSION:

The short and severe prodromal phase in PDGBA might call for shorter assessment intervals in yet premanifest GBA mutation carriers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Sintomas Prodrômicos / Glucosilceramidase / Mutação Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Sintomas Prodrômicos / Glucosilceramidase / Mutação Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article